The significant EPS beat and raised guidance—especially on expanding high-margin PBP channel sales—signal accelerating commercial traction. Traders should monitor PBP reimbursement trends and new patient start recovery in Q2, as sequential decline in new starts may pose a near-term headwind.
Price Chart
Executive Summary
Beta Bionics (BBNX) reported Q1 2026 revenue of $27.6 million, up 57% YoY and above $27.0M consensus, while net loss per share was $0.49, significantly better than the $-0.45 expected. The company raised full-year 2026 revenue guidance to $131M–$136M, up from prior $130M–$135M, driven by strong PBP channel growth and margin expansion.
Key Financial Metrics
Key Facts
- Q1 2026 revenue: $27.6 million (57% YoY growth), beats $27.0M consensus
- Net loss per share: $0.49, a 36.1% beat vs. $-0.45 estimate
- Gross margin expanded 864 bps to 59.5% YoY
- PBP channel sales surged 181% YoY to $10.7 million
- 2026 full-year revenue guidance raised to $131M–$136M from $130M–$135M
- Cash and investments: $239.5 million as of March 31, 2026
Financial Impact
Revenue beat by $0.6M (2.2%), EPS loss 36.1% narrower than expected, full-year guidance increased
Risk Factors
- New patient starts declined sequentially (10–20%) despite revenue growth, raising sustainability concerns
- Net loss remains high at $21.9M, and adjusted EBITDA still deeply negative at $-17.7M
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3278400 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | SC 13G | $18.08 | awaiting T+20 | — | $19.16 (+5.97%) |
Sep 23, 2026 4w ago | Insider Cluster | $21.76 $19.34 | ▲ +11.12% | ▲ +10.70% | $19.16 (+11.95%) |
Sep 18, 2026 5w ago | Insider Cluster | $22.04 $16.84 | ▲ +23.59% | ▲ +22.69% | $19.16 (+13.07%) |
Sep 17, 2026 5w ago | Press Release | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $19.16 (−12.47%) |
Sep 17, 2026 5w ago | Insider Cluster | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $19.16 (−12.47%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $19.16 (+13.62%) |
Sep 15, 2026 5w ago | 8-K | $22.18 $16.87 | ▼ −23.94% | ▼ −26.00% | $19.16 (−13.62%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $19.16 (+13.62%) |
Sep 14, 2026 6w ago | Press Release | $16.73 $17.86 | ▲ +6.75% | ▲ +4.49% | $19.16 (+14.52%) |
Sep 10, 2026 6w ago | Insider Cluster | $16.57 $17.63 | ▼ −6.40% | ▼ −4.53% | $19.16 (−15.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers